12:44 PM
 | 
May 07, 2018
 |  BC Extra  |  Financial News

Ascletis first to apply for HKEX biotech chapter

Ascletis Pharma Inc. (Hangzhou, China) plans to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley, Goldman Sachs and China Merchants Securities, according to a regulatory filing.

The company is the first for which an IPO application has been filed on HKEX’s new pre-revenue biotech chapter. To list on the exchange, such companies are required to...

Read the full 296 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >